Pilot study: a detailed analysis of the timing of immuno-inflammatory indices in gastric cancer, and their assessment together with TNM as supplementary prognostic factors

Rev Esp Enferm Dig. 2024 Jan;116(1):46-47. doi: 10.17235/reed.2023.9548/2023.

Abstract

An analysis of the prognostic impact of up to 36 immuno-inflammatory indices at 3 different times during the diagnostic-therapeutic process for gastric cancer. The dependent variable was disease-free survival at 3 years. The independent factors obtained were combined with TNM to provide an improved prognostic model.

MeSH terms

  • Disease-Free Survival
  • Humans
  • Neoplasm Staging
  • Pilot Projects
  • Prognosis
  • Retrospective Studies
  • Stomach Neoplasms* / pathology